Nombre del producto:3-((2-Chloropyridin-4-yl)methyl)-1-cyclobutyl-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c]isoquinolin-5(4H)-one

IUPAC Name:3-[(2-chloropyridin-4-yl)methyl]-1-cyclobutyl-3H,4H,5H,6H,7H,8H,9H-pyrazolo[3,4-c]isoquinolin-5-one

CAS:1951439-42-1
Fórmula molecular:C20H21ClN4O
Pureza:97%
Número de catálogo:CM228812
Peso molecular:368.87

Unidad de embalaje Stock disponible Precio($) Cantidad
CM228812-1g 1-2 Weeks œƐǠdž

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1951439-42-1
Fórmula molecular:C20H21ClN4O
Punto de fusión:-
Código de sonrisas:O=C1NC(N(CC2=CC(Cl)=NC=C2)N=C3C4CCC4)=C3C5=C1CCCC5
Densidad:
Número de catálogo:CM228812
Peso molecular:368.87
Punto de ebullición:
Nº Mdl:MFCD27991334
Almacenamiento:

Category Infos

Pyrazolopyridines
Over the past few years, many pyrazole fused-ring systems, especially with applications in medicinal chemistry, have been published. These include general structures such as pyrazoline, pyrazoline, pyrazoquinoline, pyrazoloisoquinoline, pyrazoline, pyrazolopyrazine, pyrazolopyrazine, pyranopyrazole, pyrano Pyrazoles, pyrazolotriazines and pyrazole fused phosphorus rings.
Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.